Finasteride + Minoxidil Combination: Clinical Trial Evidence

Finasteride and minoxidil act via complementary mechanisms, finasteride blocks DHT-mediated follicle miniaturization while minoxidil acts as a vasodilator and direct growth stimulator. Multiple trials and meta-analyses have investigated whether combining both agents produces superior outcomes to either monotherapy.

Key Evidence

Study	Design	n	Duration	Key Finding
Hu R, et al. 2015	Randomized comparative trial; 3 arms: fin alone, min alone, combination	450	12 months	Improvement in 94.1% of men on the combination vs. 80.5% on finasteride and 59% on minoxidil
Chen L, et al. 2020 (meta-analysis)	Systematic review and meta-analysis	5 RCTs	Varied by trial	Combination had higher global photographic scores and more patients with marked improvement than either drug alone, with similar safety; only 2 RCTs compared against finasteride alone

Evidence Summary

• Combination therapy is generally superior to monotherapy for hair density outcomes
• The absolute advantage is real but moderate; patients with early-to-moderate AGA may benefit most
• Both agents are FDA-approved for male AGA individually; combination use is common clinical practice though not officially labeled

Full guide: Finasteride and minoxidil combination therapy | Finasteride vs. minoxidil comparison

Sources

• Hu R, et al. “Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients.” Dermatol Ther. 2015;28(5):303-308.
• Chen L, et al. “The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis.” Aesthetic Plast Surg. 2020;44(3):962-970.